Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bevacizumab and nimustine are effective in
the treatment of recurrent high grade glioma and to explore whether there is any subgroup
being sensitive to this therapeutic protocol.